Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams?
| Autor: | N. Bige, E. Canoui, J. Tankovic, G. Offenstadt, M. Alves |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Adult
Male Carbapenem medicine.medical_treatment Microbial Sensitivity Tests beta-Lactams beta-Lactam Resistance beta-Lactamases Substrate Specificity Microbiology Beta-lactam chemistry.chemical_compound Bacterial Proteins Enterobacteriaceae Drug Resistance Multiple Bacterial medicine Humans Aged Retrospective Studies Aged 80 and over Cross Infection business.industry Enterobacteriaceae Infections Middle Aged Anti-Bacterial Agents Imipenem Intensive Care Units Infectious Diseases chemistry Beta-lactamase Female France business medicine.drug |
| Zdroj: | Médecine et Maladies Infectieuses. 44:235-237 |
| ISSN: | 0399-077X |
| DOI: | 10.1016/j.medmal.2014.03.006 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect